UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000044605 |
|---|---|
| Receipt number | R000050889 |
| Scientific Title | Impact of attenuating the requirement for abstract submissions at a scientific meeting on the number of the submissions and the number of the scientific association members |
| Date of disclosure of the study information | 2021/06/21 |
| Last modified on | 2022/12/22 12:12:24 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Impact of attenuating the requirement for abstract submissions at a scientific meeting on the number of the submissions and the number of the scientific association members
Acronym
Impact of attenuating the requirement for abstract submissions at a scientific meeting on the number of the submissions and the number of the scientific association members
Scientific Title
Impact of attenuating the requirement for abstract submissions at a scientific meeting on the number of the submissions and the number of the scientific association members
Scientific Title:Acronym
Impact of attenuating the requirement for abstract submissions at a scientific meeting on the number of the submissions and the number of the scientific association members
Region
| Japan |
Condition
Condition
None (Healthy)
Classification by specialty
| Nursing | Adult |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
When the requirement that co-presenters be members is removed from the eligibility requirements for abstract at scientific meetings, we aim to (1) know how many abstracts will increase, (2) know how many co-presenters would have joined if the previous requirement had been in place, and (3) estimate the impact on the total revenue of admission fee, annual membership fee, and participation fee.
Basic objectives2
Others
Basic objectives -Others
descriptive
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
Number of abstracts
Key secondary outcomes
Number of co-presenters
Estimated revenue
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
First presenter of the accepted abstract for the 28th Annual Meeting of the Japanese Association for Research for Family Nursing
Key exclusion criteria
No
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Iori |
| Middle name | Sato |
| Last name | Sato |
Organization
The University of Tokyo
Division name
Division of Health Sciences and Nursing, Department of Family Nursing
Zip code
113-0033
Address
Hongo 7-3-1, Bunkyo-ku, Tokyo
TEL
0358413691
satoi-tky@umin.ac.jp
Public contact
Name of contact person
| 1st name | Iori |
| Middle name | |
| Last name | Sato |
Organization
Graduate School of Medicine, the University of Tokyo
Division name
Division of Health Sciences and Nursing, Department of Family Nursing
Zip code
113-0033
Address
Hongo 7-3-1, Bunkyo-ku, Tokyo
TEL
0358413691
Homepage URL
satoi-tky@umin.ac.jp
Sponsor or person
Institute
The University of Tokyo
Institute
Department
Personal name
Funding Source
Organization
The University of Tokyo
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Research Ethics Committee, Graduate School of Medicine, The University of Tokyo
Address
Hongo 7-3-1, Bunkyo-ku, Tokyo
Tel
03-5841-0818
ethics@m.u-tokyo.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2021 | Year | 06 | Month | 21 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2021 | Year | 05 | Month | 17 | Day |
Date of IRB
| 2021 | Year | 05 | Month | 26 | Day |
Anticipated trial start date
| 2021 | Year | 07 | Month | 19 | Day |
Last follow-up date
| 2021 | Year | 10 | Month | 03 | Day |
Date of closure to data entry
| 2021 | Year | 10 | Month | 03 | Day |
Date trial data considered complete
| 2021 | Year | 10 | Month | 06 | Day |
Date analysis concluded
| 2021 | Year | 10 | Month | 06 | Day |
Other
Other related information
Observational study
A single web-based questionnaire survey will be conducted for the first presenter of accepted abstracts.
First, if the eligibility requirements for submitting a general abstract had been "both the first author and co-presenter must be members" as before, we will ask whether they would have submitted the abstract they submitted this time. Next, since the first author must be a member at the time of application, ask whether he or she joined the Japanese Society of Family Nursing on the occasion of this general abstract application, or whether he or she was a member regardless of this general abstract application. In addition, if there are co-presenters, ask if each co-presenter is a member. Finally, non-member co-presenters will be asked what they would have done if they had been required to be members under the previous requirements.
Analysis will be conducted by a researcher who does not know the content of the abstracts or the individual speakers. The number of members and non-members at the time of abstract submission is counted for co-presenters who are non-members of "Abstracts submitted even though they are members". In this case, in order to estimate the number of co-presenters who would have joined under the conventional requirements, the ratio of the number of co-presenters who "became members" and those who "were removed as co-presenters" is calculated, and those who "do not know" or "were left to their own devices" are considered to have either become members or been removed as co-presenters according to the ratio of the number of co-presenters. Although there is a possibility that the same person may actually be the first and co-presenters, we will not consider duplication because of ethical considerations such as not identifying the individual presenters and the fact that those involved in multiple presentations are likely to be original members who are deeply involved in family nursing and will not affect the results.
Management information
Registered date
| 2021 | Year | 06 | Month | 21 | Day |
Last modified on
| 2022 | Year | 12 | Month | 22 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000050889
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
